In this multiple-dose to steady-state study , participants received once-daily subcutaneous administrations of either @ ( cohort @ ) or @ units kg ( -@ ) ( cohort @ ) Gla-@ for @ days in one treatment period and @ units kg ( -@ ) Gla-@ for @ days in the other .